LuxExperience BV
- Market cap
- 1.44B
- P/E (TTM)i
- -7.67
- P/Bi
- 1.05
- EPSi
- -1.34
- Div yieldi
- 0.00%
- 52W posi
- 78%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 99.67% -0.02pp
- Institutions
- 67 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
45 filings tracked · 0 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Martin Beer | CFO & Member of Management Board | 1.36% |
| Nora Aufreiter | Independent Chairman of the Supervisory Board | 0.05% |
| Sascha Zahnd | Independent Member of Supervisory Board | 0.05% |
| Susan Saideman | Officer | 0.05% |
| Michaela Margarete Tod | Independent Member of Supervisory Board | 0.05% |
| Marjorie Lao | Independent Vice-Chairman of Supervisory Board | 0.05% |
| Ernst Teunissen | -- | -- |
| Michael Kliger | CEO & Chairman of Management Board | -- |
| Sebastian Dietzmann | COO & Member of Management Board | -- |
| Gareth Locke | Chief Growth Officer & Member of Management Board | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Michael Kliger | CEO & Chairman of Management Board | Derivative Exercise and Sale | -76,008 | $8.68–10.08 |
| 2026-10-01 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -2,598 | $10.00 |
| 2026-09-30 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -73,410 | $9.91 |
| 2026-09-17 | Michael Kliger | CEO & Chairman of Management Board | Derivative Exercise and Sale | -75,412 | $8.68–10.02 |
| 2026-03-17 | Marjorie Lao | Independent Vice-Chairman of Supervisory Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Martin Beer | CFO & Member of Management Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Ernst Teunissen | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Michael Kliger | CEO & Chairman of Management Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Nora Aufreiter | Independent Chairman of the Supervisory Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Sascha Zahnd | Independent Member of Supervisory Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Michaela Margarete Tod | Independent Member of Supervisory Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Susan Saideman | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-02-10 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -204,624 | $9.36 |
| 2025-10-27 | Martin Beer | CFO & Member of Management Board | Intent to Sell (Form 144) | -3,165 | $9.47 |
| 2025-10-23 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -2,087,906 | $9.22 |
| 2025-07-27 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -274,174 | $8.23 |
| 2025-07-22 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -244,916 | $7.76 |
| 2025-07-02 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -108,375 | $7.61 |
| 2025-06-23 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -219,914 | $7.66 |
| 2025-06-10 | Michael Kliger | CEO & Chairman of Management Board | Intent to Sell (Form 144) | -275,767 | $9.27 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.